Rexall Sundown
This article was originally published in The Tan Sheet
Executive Summary
Second quarter net sales up 78% to $115.5 mil. for the period ended Feb. 28; pro forma net income increased 67% to $14.7 mil. Pro forma income reflects a tax provision for the recently acquired Richardson Labs prior to its purchase in January. Income results also reflect approximately $2.5 mil. in expenses related to the acquisition. Sales to retailers rose 95% during the quarter and the Rexall Showcase International direct sales division posted a 61% gain. The company said its Osteo Bi-Flex product "remains the third best selling nutritional supplement in the country" and its Sundown herbals line is the number one selling herbals line in U.S. food, drug and mass market outlets. The company also announced retirement of Dean DeSantis as chief operating officer to pursue other interests. A successor has not yet been named...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning